Using a murine model, the ablation of progesterone receptor membrane component 2 (Pgrmc2) was shown to attenuate the timing, aggression, and lethality of Pten loss-of-function-induced endometrial hyperplasia and cancer. The gene discussed is PGRMC2; the disease is cancer.